Designer Brands Inc. (DBI) as of January 31, 2026 presents a deeply negative liquidation recovery posture. MFFAIS-reported CLV of approximately -$1.58B and LLV of approximately -$1.52B confirm equity is substantially impaired under a wind-down scenario. Total assets of $1.95B are dominated by ASC 842 operating lease ROU assets ($675.6M, 35% of total assets, zero recovery under liquidation lens), goodwill ($130.8M, zero recovery), and other intangibles ($81.2M, zero recovery). Inventory of $563.5M at a 60% recovery rate yields approximately $338M; cash of $50.9M recovers at par; net receivables of $59.4M recover at ~90-95%, or ~$55M. Gross tangible recoverable asset pool is therefore approximately $444M before liabilities. Against this, total liabilities stand at $1.66B at face value, including $428.2M net long-term debt (with $431.9M maturing in fiscal year two per maturity schedule), $772.1M in operating lease liabilities that do not extinguish on wind-down, and $30.8M in finance lease liabilities. The structural liability overhang from ASC 842 leases alone (~$803M combined operating and finance) overwhelms the recoverable tangible asset base. Accounts payable of $236.2M and accrued liabilities of $170M add further current claim priority. The ABL Revolver (post-February 27, 2026 amendment, maturity now tied to the earlier of Term Loan maturity in June 2028 or February 2031) had $394.2M borrowing base with $101.1M availability at period end, indicating meaningful draw utilization. Term Loan carries $438.7M gross face, with $431.9M due in year two. Net sales declined from $3.01B (FY2024) to $2.89B (FY2025), a 3.9% contraction. Impairment charges moderated to $4.4M in FY2025 from $18.3M in FY2024, but the filing explicitly flags goodwill and indefinite-lived tradename impairment risk given macroeconomic softness, tariff exposure, and stock price volatility. The Brand Portfolio segment, which generates intersegment supply to Retail, has five customers comprising approximately 38% of external segment sales, creating concentration risk that would impair orderly wind-down proceeds. Equity method investment of $56.3M carries uncertain liquidation value. Filing discusses licensing royalty commitments of $101.5M ($33.8M annually for three years) in MD&A but this concept does not appear as a separately tagged XBRL item distinct from OtherCommitment; it is embedded there and treated as a face-value liability in liquidation. The post-period ABL amendment and continued $0.05/share quarterly dividend signal management views going concern as intact, but the balance-sheet recovery calculus remains materially negative.
▼ Community Notes